Understanding the cancer-killing properties of a chemical commando

March 1, 2016 by Jim Shelton
Understanding the cancer-killing properties of a chemical commando
This rendering displays aspects of the solution structure of lomaiviticin A.

A Yale lab has unlocked the process by which a natural anti-cancer agent is able to bind to DNA and directly break both strands.

The discovery may be helpful in developing synthetic molecules for cancer therapies that can effectively disrupt the replication of DNA in , say the researchers. The findings appeared online in the journal Proceedings of the National Academy of Sciences the week of Feb. 29.

"DNA is the canonical target for cancer treatment," said Seth Herzon, a chemistry professor at Yale and corresponding author of the study. "Because are proliferating, they need to replicate their DNA more rapidly than healthy cells."

For nearly a decade, Herzon's lab has investigated certain chemical properties of lomaiviticin A, a natural byproduct of marine bacteria found on coral reefs. Lomaiviticin A has been shown to be effective in cleaving both strands of the DNA structure—to form what are known as double-strand breaks—but until now, scientists did not understand the process.

"A lot of compounds are able to damage DNA, but relatively few induce double-strand breaks directly. These are the most lethal type of lesions to the tumor cell," Herzon explained.

Using sophisticated, computational modeling, plus spectroscopy, the researchers were able to find the key: proximity. Lomaiviticin A has the ability to bind with DNA in such a way that it places two essential reactive parts of the molecule in close proximity to each DNA strand.

"Lomaiviticin is like a chemical Navy SEAL," Herzon said. "It has been bred to shred DNA. Now that we understand its capabilities and how it works, we want to harness its awesome power for therapeutic purposes. We also need to keep it from wandering off and causing trouble, and make sure it carries out its operations with precision and efficiency."

The study's first author is Christina Woo, a former member of Herzon's lab who is now a postdoctoral fellow at Stanford. Co-authors are Zhenwu Li, a former Yale postdoc who is now at Incyte Pharmaceuticals; and Eric Paulson, NMR manager in Yale's Department of Chemistry.

Explore further: Rare byproduct of marine bacteria kills cancer cells by snipping their DNA

More information: Christina M. Woo et al. Structural basis for DNA cleavage by the potent antiproliferative agent (–)-lomaiviticin A, Proceedings of the National Academy of Sciences (2016). DOI: 10.1073/pnas.1519846113

Related Stories

Scientists Synthesize Unique Family of Anti-Cancer Compounds

February 12, 2010

(PhysOrg.com) -- Yale University scientists have streamlined the process for synthesizing a family of compounds with the potential to kill cancer and other diseased cells, and have found that they represent a unique category ...

Scientists synthesize long-sought-after anticancer agent

January 31, 2011

A team of Yale University scientists has synthesized for the first time a chemical compound called lomaiviticin aglycon, leading to the development of a new class of molecules that appear to target and destroy cancer stem ...

A defense protein that causes cancer

January 22, 2016

Cancer is caused by the growth of an abnormal cell which harbours DNA mutations, "copy errors" occurring during the DNA replication process. If these errors do take place quite regularly without having any damaging effect ...

Recommended for you

Hydrogen from sunlight—but as a dark reaction

December 9, 2016

The storage of photogenerated electric energy and its release on demand are still among the main obstacles in artificial photosynthesis. One of the most promising, recently identified photocatalytic new materials is inexpensive ...

Cloud formation—how feldspar acts as ice nucleus

December 9, 2016

In the atmosphere, feldspar particles act as ice nuclei that make ice crystals grow in clouds and enable precipitation. The discovery was made by researchers of Karlsruhe Institute of Technology (KIT) and University College ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.